# TYRA (Tyra Biosciences, Inc.) - SEC EDGAR Financial Statements

> Tyra Biosciences, Inc. reported $727.5M in total assets and a net loss of $169.8M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/TYRA
- Markdown: https://convexityos.com/fundamentals/TYRA.md
- SEC CIK: 0001863127
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:26 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001863127&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$182.4M | Operating profit |
| Net Income | FY 2025 | -$169.8M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$2.46 | Split-adjusted |
| Free Cash Flow | FY 2025 | -$119.8M | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $456.0M | Total debt: $5.46M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $102.9M | $80.08M | $62.52M | $43.01M | $20.64M | $7.20M |
| Total Operating Expenses | $132.8M | $104.2M | $79.94M | $58.93M | $26.29M | $9.30M |
| **Operating Income** | -$132.8M | -$104.2M | -$79.94M | -$58.93M | -$26.29M | -$9.30M |
| **EBITDA** | -$132.2M | -$103.7M | -$79.59M | -$58.63M | -$26.15M | -$9.25M |
| Income Tax Expense | $0 | $0 | $0 | $2.0K | $1.0K | $1.0K |
| **Net Income** | -$119.9M | -$86.48M | -$69.13M | -$55.33M | -$26.29M | -$9.34M |
| Basic EPS | -$2.01 | -$1.51 | -$1.62 | -$1.32 | -$1.91 | -$6.05 |
| **Diluted EPS** | -$2.01 | -$1.51 | -$1.62 | -$1.32 | -$1.91 | -$6.05 |
| Basic Shares Outstanding | 59.6M | 57.2M | 42.7M | 41.9M | 13.8M | 1.5M |
| Diluted Shares Outstanding | 59.6M | 57.2M | 42.7M | 41.9M | 13.8M | 1.5M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Research & Development | $43.14M | $39.20M | $33.47M | $28.19M | $25.47M | $24.31M | $24.96M | $22.18M |
| Total Operating Expenses | $54.88M | $49.00M | $42.00M | $36.52M | $32.94M | $31.45M | $31.85M | $29.74M |
| **Operating Income** | -$54.88M | -$49.00M | -$42.00M | -$36.52M | -$32.94M | -$31.45M | -$31.85M | -$29.74M |
| **EBITDA** | -$54.76M | -$48.87M | -$41.86M | -$36.38M | -$32.81M | -$31.31M | -$31.71M | -$29.60M |
| **Net Income** | -$51.12M | -$45.56M | -$39.30M | -$33.83M | -$29.87M | -$28.10M | -$28.15M | -$25.57M |
| Basic EPS | -$0.74 | -$0.69 | -$0.64 | -- | -$0.50 | -$0.47 | -$0.47 | -- |
| **Diluted EPS** | -$0.74 | -$0.69 | -$0.64 | -- | -$0.50 | -$0.47 | -$0.47 | -- |
| Basic Shares Outstanding | 69.1M | 66.0M | 61.7M | -- | 59.7M | 59.6M | 59.3M | -- |
| Diluted Shares Outstanding | 69.1M | 66.0M | 61.7M | -- | 59.7M | 59.6M | 59.3M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $77.39M | $91.97M | $58.01M | $251.2M | $302.2M | $15.22M |
| **Cash & Short-Term Investments** | $77.39M | $91.97M | $58.01M | $251.2M | $302.2M | $15.22M |
| **Total Current Assets** | $265.4M | $347.5M | $211.7M | $257.3M | $304.1M | $15.28M |
| Property, Plant & Equipment, Net | $1.31M | $1.65M | $1.63M | $1.08M | $1.03M | $297K |
| Other Non-Current Assets | $9.27M | $7.38M | $5.03M | $4.35M | $312K | $21K |
| **Total Non-Current Assets** | $17.16M | $16.09M | $14.19M | $8.89M | $2.64M | $730K |
| **Total Assets** | $282.6M | $363.6M | $225.9M | $266.2M | $306.7M | $16.01M |
| Accounts Payable | $1.18M | $590K | $4.66M | $1.15M | $599K | $664K |
| **Total Current Liabilities** | $18.09M | $14.59M | $15.33M | $5.70M | $3.62M | $1.86M |
| Other Non-Current Liabilities | $0 | $3.0K | $46K | $169K | $367K | $140K |
| **Total Non-Current Liabilities** | $5.34M | $5.81M | $6.26M | $2.65M | $1.35M | $140K |
| **Total Liabilities** | $23.43M | $20.41M | $21.59M | $8.35M | $4.96M | $2.00M |
| **Total Debt (incl. Leases)** | $5.81M | $6.22M | $6.50M | $2.62M | $1.18M | $151K |
| Common Stock | $5.0K | $5.0K | $4.0K | $4.0K | $4.0K | $0 |
| Retained Earnings | -$371.3M | -$251.3M | -$164.8M | -$95.70M | -$40.37M | -$14.08M |
| Accumulated Other Comp. Income | $393K | $770K | $381K | $0 | -- | -- |
| **Total Stockholders' Equity** | $259.2M | $343.2M | $204.3M | $257.8M | $301.7M | -$13.64M |
| Total Equity | $259.2M | $343.2M | $204.3M | $257.8M | $301.7M | -$13.64M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $456.0M | $73.83M | $84.95M | $77.39M | $61.95M | $98.49M | $100.7M | $91.97M |
| **Cash & Short-Term Investments** | $456.0M | $73.83M | $84.95M | $77.39M | $61.95M | $98.49M | $100.7M | $91.97M |
| **Total Current Assets** | $711.6M | $367.0M | $394.6M | $265.4M | $281.2M | $302.2M | $324.6M | $347.5M |
| Property, Plant & Equipment, Net | $1.08M | $1.17M | $1.22M | $1.31M | $1.35M | $1.41M | $1.52M | $1.65M |
| Other Non-Current Assets | $8.76M | $9.03M | $9.88M | $9.27M | $12.59M | $11.11M | $10.44M | $7.38M |
| **Total Non-Current Assets** | $15.91M | $16.40M | $17.43M | $17.16M | $20.64M | $19.34M | $18.91M | $16.09M |
| **Total Assets** | $727.5M | $383.4M | $412.0M | $282.6M | $301.9M | $321.5M | $343.5M | $363.6M |
| Accounts Payable | $3.30M | $2.33M | $3.64M | $1.18M | $1.99M | $2.25M | $2.50M | $590K |
| **Total Current Liabilities** | $29.74M | $24.62M | $19.26M | $18.09M | $15.88M | $13.77M | $14.25M | $14.59M |
| Other Non-Current Liabilities | -- | -- | -- | $0 | $0 | $0 | $0 | $3.0K |
| **Total Non-Current Liabilities** | $4.94M | $5.08M | $5.21M | $5.34M | $5.46M | $5.58M | $5.70M | $5.81M |
| **Total Liabilities** | $34.68M | $29.70M | $24.46M | $23.43M | $21.34M | $19.35M | $19.94M | $20.41M |
| **Total Debt (incl. Leases)** | $5.46M | $5.58M | $5.70M | $5.81M | $5.92M | $6.02M | $6.12M | $6.22M |
| Common Stock | $7.0K | $6.0K | $6.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K |
| Retained Earnings | -$507.2M | -$456.1M | -$410.6M | -$371.3M | -$337.4M | -$307.6M | -$279.5M | -$251.3M |
| Accumulated Other Comp. Income | -$1.28M | -$580K | $107K | $393K | $442K | $436K | $688K | $770K |
| **Total Stockholders' Equity** | $692.8M | $353.7M | $387.6M | $259.2M | $280.5M | $302.1M | $323.5M | $343.2M |
| Total Equity | $692.8M | $353.7M | $387.6M | $259.2M | $280.5M | $302.1M | $323.5M | $343.2M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$119.9M | -$86.48M | -$69.13M | -$55.33M | -$26.29M | -$9.34M |
| Depreciation & Amortization | $546K | $519K | $357K | $296K | $140K | $47K |
| Stock-Based Compensation | $28.01M | $22.80M | $13.53M | $10.59M | $2.89M | $439K |
| **Operating Cash Flow** | -$95.14M | -$69.77M | -$50.14M | -$50.28M | -$23.75M | -$7.76M |
| Capital Expenditure | -$141K | -$664K | -$770K | -$559K | -$661K | -$312K |
| **Free Cash Flow** | -$95.28M | -$70.44M | -$50.91M | -$50.84M | -$24.41M | -$8.07M |
| Purchases of Investments | -$101.3M | -$263.6M | -$143.8M | $0 | -- | -- |
| **Investing Cash Flow** | $72.46M | -$98.40M | -$144.6M | -$559K | -$645K | -$312K |
| **Financing Cash Flow** | $8.10M | $202.1M | $1.54M | $632K | $311.3M | $23.43M |
| **Net Change in Cash** | -$14.58M | $33.96M | -$193.2M | -$50.21M | $287.0M | $15.36M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$51.12M | -$45.56M | -$39.30M | -$33.83M | -$29.87M | -$28.10M | -$28.15M | -$25.57M |
| Depreciation & Amortization | $130K | $138K | $138K | $132K | $131K | $140K | $143K | $144K |
| Stock-Based Compensation | $12.16M | $10.23M | $7.85M | $7.63M | $7.58M | $6.38M | $6.42M | $6.70M |
| **Operating Cash Flow** | -$32.21M | -$31.08M | -$32.57M | -$23.62M | -$22.38M | -$23.68M | -$25.46M | -$19.59M |
| Capital Expenditure | -$90K | -$66K | -$88K | -$57K | -$39K | -$31K | -$14K | -$6.0K |
| **Free Cash Flow** | -$32.30M | -$31.14M | -$32.66M | -$23.68M | -$22.42M | -$23.71M | -$25.47M | -$19.60M |
| Purchases of Investments | -$18.99M | -$22.08M | -$162.2M | -$9.11M | -$65.17M | -$20.11M | -$6.87M | -$38.04M |
| **Investing Cash Flow** | $34.92M | $17.85M | -$120.2M | $34.38M | -$14.81M | $20.87M | $32.03M | $6.96M |
| Common Stock Issued | -$1.0K | $0 | $147.9M | -- | $0 | $0 | $0 | -- |
| **Financing Cash Flow** | $379.5M | $2.10M | $160.4M | $4.68M | $647K | $583K | $2.19M | $706K |
| **Net Change in Cash** | $382.2M | -$11.12M | $7.57M | $15.44M | -$36.54M | -$2.23M | $8.76M | -$11.93M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -46.3% | -25.2% | -33.8% | -21.5% | -8.7% | -- |
| Return on Assets (ROA) | -42.4% | -23.8% | -30.6% | -20.8% | -8.6% | -58.3% |
| Current Ratio | 14.67x | 23.81x | 13.80x | 45.13x | 84.09x | 8.22x |
| Quick Ratio | 4.28x | 6.30x | 3.78x | 44.06x | 83.57x | 8.19x |
| Debt to Equity | 0.02x | 0.02x | 0.03x | 0.01x | 0.00x | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Equity (ROE) | -24.5% | -42.0% | -33.8% | -46.3% | -39.8% | -35.0% | -29.8% | -25.2% |
| Return on Assets (ROA) | -23.3% | -38.8% | -31.8% | -42.4% | -37.0% | -32.9% | -28.1% | -23.8% |
| Current Ratio | 23.93x | 14.91x | 20.49x | 14.67x | 17.71x | 21.94x | 22.78x | 23.81x |
| Quick Ratio | 15.33x | 3.00x | 4.41x | 4.28x | 3.90x | 7.15x | 7.07x | 6.30x |
| Debt to Equity | 0.01x | 0.02x | 0.01x | 0.02x | 0.02x | 0.02x | 0.02x | 0.02x |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
